Assort Health is a healthcare voice AI company addressing one of medicine's most persistent operational pain points: the patient phone line. Front desks at clinics and health systems are buried under inbound calls for scheduling, prescription questions, and routine requests, producing long hold times, abandoned calls, and frustrated patients and staff alike. Assort Health builds AI voice agents specifically designed to absorb that call volume and resolve requests end to end.
What distinguishes Assort is its specialty-specific approach. Rather than a generic phone bot, Assort tailors its generative AI to the workflows, terminology, and scheduling logic of particular medical specialties, which it argues is essential to handling real patient conversations accurately. Crucially, the agents integrate directly with clinical electronic health record (EHR) and practice-management systems, so they can actually book appointments, route requests, and act on patient needs rather than just take messages.
Reliability and safety are central in healthcare, and Assort emphasizes accuracy and appropriate handling of sensitive interactions. By deflecting routine calls and reducing hold times, the company aims to improve both patient experience and staff productivity, while capturing demand that would otherwise be lost to busy signals and abandoned calls.
Assort Health was founded by Jon Wang and Jeff Liu, whose backgrounds span Apple, Stanford, Commure, and Meta. In April 2025 it secured a $22M Series A led by First Round Capital and Chemistry, with participation from Quiet Capital, Four Acres, Tau Ventures, and healthcare angels, bringing total funding to $26M. In September 2025 the company announced a $76M Series B led by Lightspeed Venture Partners, taking total funding to about $102M and underscoring rapid traction for voice AI in healthcare patient access.